Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > T would not be surprised

<< Previous

Bullboard Posts

Next >>

Comment by postie1on May 08, 2023 3:49pm

140 Views

Post# 35437082

RE:RE:T would not be surprised

Thank you whitenorth and I hope I am right about the flow of news. I am basing my opinion on the news based on length of time for those tests and I do not think VMs management has been sitting on their hands doing nothing while waiting for the FDA decision plus the fact they seem to bevery small investor friendly and probably know those transfer rules..
And I know it has not been as fast as some people would like but are not the only business to have things derailed by CoVid. DYDD

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record